Athens Greece October News Today : Breaking News, Live Updates & Top Stories | Vimarsana

JERSEY CITY, N.J., Oct. 24, 2023 (GLOBE NEWSWIRE) SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced the presentation of preclinical data on its second generation fungerp candidate, SCY-247, against a broad panel of fungal pathogens. The analyses were presented by Mahmoud Ghannoum, Ph.D, Professor and Director Center for Medical Mycology, Case Western Reserve Universit ....

Mahmoud Ghannoum , Martin Hoenigl , Irina Koffler , Case Western Reserve University , European Confederation Of Medical Mycology , Scynexis Inc , Drug Administration , Globe Newswire Scynexis Inc , Congress On Trends In Medical Mycology , Director Center , Medical Mycology , Oral Triterpenoid Antifungal , Vitro Activity Against , Fungal Pathogens , Athens Greece October , Associate Professor , Translational Mycology , European Confederation , Infectious Disease Product , Fast Track , Private Securities Litigation Reform Act , Annual Report , Fungal Pathogens , Case Western Reserve University , Oral Presentation , Antifungal Resistance ,